For complex, multifactorial issues like chronic sciatica, researchers often study them in tandem to see if they produce a synergistic effect
Frequency and Timing of Dizziness on Tirzepatide Clinical trials of tirzepatide report dizziness in roughly 58% of participants across all dose levels, with most incidents occurring in the first two to four weeks of treatment
Clin Chem 18:499502 Gabriel MM, Ehrenbauer AF, Lichtinghagen R et al (2023) P24 the diagnostic value of acetylcholinesterase activity in minimal hepatic encephalopathy: an ongoing need for biomarkers
Headache Pain 45 PiniL
A., Derry, S., Aldington, D., Cole, P
Clinical trial data from the phase 2 study shows that retatrutide at 4mg and above produces statistically significant reductions in desire for sweet foods by week 4, with participants reporting 14 to 19.5 point improvements on appetite visual analog scales compared to placebo